0455 Share Price

Open 0.42 Change Price %
High 0.42 1 Day 0.00 0.00
Low 0.41 1 Week 0.00 0.00
Close 0.42 1 Month -0.04 -8.70
Volume 956000 1 Year 0.06 16.67
52 Week High 0.57
52 Week Low 0.36
0455 Important Levels
Resistance 2 0.43
Resistance 1 0.43
Pivot 0.42
Support 1 0.41
Support 2 0.41
HKG HongKong Most Active Stocks
0364 0.03 -25.00%
0136 0.20 -20.00%
0566 3.91 0.00%
0061 0.02 0.00%
3988 3.51 -1.13%
0939 5.79 -1.03%
0381 0.08 0.00%
1076 0.15 0.00%
0030 0.15 7.14%
0261 0.01 0.00%
More..
HKG HongKong Top Gainers Stocks
2168 4.60 17.65%
0582 0.07 16.67%
8129 0.08 14.29%
0621 0.09 12.50%
2302 2.87 11.67%
2882 0.10 11.11%
8163 0.10 11.11%
3318 2.12 10.42%
8321 9.40 10.33%
8088 0.11 10.00%
More..
HKG HongKong Top Losers Stocks
4338 80.00 -38.93%
4333 60.00 -25.00%
0364 0.03 -25.00%
0136 0.20 -20.00%
8351 0.10 -16.67%
8272 0.05 -16.67%
8002 4.00 -15.97%
8201 0.07 -12.50%
8262 0.89 -11.88%
0193 0.08 -11.11%
More..

Yunnan Enterprises (HKG: 0455)

0455 Technical Analysis 4
As on 20th Jan 2017 0455 Share Price closed @ 0.42 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.46 & Strong Sell for SHORT-TERM with Stoploss of 0.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
0455 Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
0455 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.tiandapharma.com
0455 Address
0455
CITIC Tower
24th Floor
Central,
Hong Kong
Phone: 852 2545 3313
Fax: 852 2541 6558
0455 Latest News
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing ...   PR Newswire (press release)   - 06th Oct 16
K2 Principal Fund L.P. to Vote Against the Incumbent Board of Eastern Platinum ...   Canada NewsWire (press release)   - 30th Jun 16
Aslan Pharma raises additional $9m led by MVP Capital Partners; closes Series ...   DEALSTREETASIA   - 07th Jan 16
ASLAN Raises US$34 Million For Immuno-Oncology   Asian Scientist Magazine   - 18th Dec 15
Aslan Pharma raises $47.9m in fresh funding   AsiaOne   - 08th Dec 15
Singapore: Aslan Pharma raises $34m in Series C funding from Temasek unit   DEALSTREETASIA   - 07th Dec 15
Shanghai Pharmaceuticals Achieves Steady Growth of Revenue and Profit for 1H2015   ACN Newswire (press release)   - 26th Aug 15
Sex, drugs and videotape   The Sunday Times   - 28th Jun 14
World Oil & Gas Pipe Market   PR Newswire (press release)   - 05th Nov 13
Western Desert Resources securing 100% of Northern Territory iron ore lease   Proactive Investors Australia   - 14th Dec 12
Interactive Technical Analysis Chart Yunnan Enterprises ( 0455 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Yunnan Enterprises
0455 Business Profile
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. Its principal product is Cerebroprotein Hydrolysate injection for treating craniocerebral trauma, and improving sequelae of cerebrovascular and deficiency of brain function, as well as for patients who lack protein or with neurasthenia. The company also provides ZhiKang granule for improving blood circulation and eliminating vascular plaques; Valsartan capsule, an antihypertensive drug; and Aceglutamide injection for traumatic brain injury coma, coma caused by nerve surgery, hepatic coma and paralysis, paraplegia, polio sequelae, nervous headache, low back pain, etc. It operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.